Latham & Watkins Advises on Sale of ZAVA to Hims & Hers Health

Latham & Watkins LLP has advised the shareholders of ZAVA Global GmbH, a listed, leading digital health platform in Europe, in their agreement for the sale of the company to Hims & Hers Health, Inc., a leading US health and wellness platform with its seat in San Francisco. With this strategic transaction, Hims & Hers aims to expand its footprint in Europe, including the United Kingdom, Germany, France, and Ireland.

The transaction is expected to close in the second half of 2025.

The Latham team was led by Hamburg corporate/M&A partner Henning C. Schneider and counsel Jacob Fontaine, with associates Juan Garcia Jacobsen, Jakob Baldes, Joscha Müller, Ivo Wanwitz, Florian Brüggemann, Antanas Grimalauskas, and Astrid Preuss. Advice was also provided on tax matters by Hamburg partner Tobias Klass; on corporate/healthcare and life sciences matters by Hamburg partner Christoph Engeler, with associate Henrietta Ditzen; on antitrust/FDI matters by Hamburg partner Jana Dammann de Chapto, with associates Helena Hofmann and Josephine Levy; on corporate matters by associate Samantha Peacock; on financial regulatory matters by Frankfurt partner Axel Schiemann; and on employment matters by Munich partner Tobias Leder and London partner Sarah Gadd.

Shareholders of ZAVA Global GmbH were also supported by the legal advisors of ZAVA Global GmbH AHB Rechtsanwälte Steuerberater in corporate matters and GNP Rechtsanwälte in healthcare and life sciences matters.